MYSM1 attenuates osteoarthritis by recruiting PP2A to deubiquitinate and dephosphorylate RIPK2
Abstract Osteoarthritis (OA), the most prevalent degenerative joint disease, is marked by cartilage degradation and pathological alterations in surrounding tissues. Currently, no effective disease-modifying treatments exist. This study aimed to elucidate the critical roles of Myb-like, SWIRM, and MP...
Saved in:
Main Authors: | Kang Wei, Chuankun Zhou, Zixing Shu, Xingru Shang, Yi Zou, Wei Zhou, Huanhuan Xu, Yulin Liang, Tian Ma, Xuying Sun, Jun Xiao |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2025-01-01
|
Series: | Bone Research |
Online Access: | https://doi.org/10.1038/s41413-024-00368-y |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Importance of Ubiquitination and Deubiquitination in Cellular Reprogramming
by: Bharathi Suresh, et al.
Published: (2016-01-01) -
The role of ubiquitination and deubiquitination in cancer lipid metabolism
by: Yongkang Xu, et al.
Published: (2025-01-01) -
Development and experimental validation of dephosphorylation-related biomarkers to assess prognosis and immunotherapeutic response in gliomas
by: Hui Tang, et al.
Published: (2025-01-01) -
Artificial intelligence-enabled discovery of a RIPK3 inhibitor with neuroprotective effects in an acute glaucoma mouse model
by: Xing Tu, et al.
Published: (2025-01-01) -
The Role of Deubiquitinating Enzymes in Synaptic Function and Nervous System Diseases
by: Jennifer R. Kowalski, et al.
Published: (2012-01-01)